Cytomed Therapeutics Pte. Ltd IPOs Tomorrow, Here's What You Need To Know

CytoMed Therapeutics Pte. Ltd GDTC IPO will take place April, 14 on the NASDAQ exchange under the ticker GDTC.

The company is offering shares at an expected price between $4.00 and $5.00 per share with an insider lock-up period of 180 days ending on October 11, 2023.

See also: Benzinga IPO Calendar

About CytoMed Therapeutics Pte. Ltd

CytoMed Therapeutics Pte. Ltd is a pre-clinical biopharmaceutical company focused on the R&D of allogeneic, "off-the-shelf" cell-based immunotherapies for treatment of human cancers. The development of our novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into treatment of solid tumors

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.